Abstract
Nephrotoxicity limits the clinical utility of aminoglycosides (Lietman, 1985). Therefore, the identification of factors associated with a greater incidence of renal damage is critical. These factors can be classified in those related to the drug and its administration and those related to the clinical condition of the patient (Table 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blaser, J., Stone, B.B. and Zinner, S.H. 1985. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment model. Antimicrob. Agents Chemother. 27: 343–349.
Collier, V.V., Lietman, P.S. and Mitch, W.E. 1979. Evidence of luminal uptake of gentamicin in the perfused rat kidney. J. Pharmacol. Exp. Ther. 210: 247–251.
Craig, W.A. and Vogelman, B. 1987. The postantibiotic effect. Ann. Intern. Med. 106: 900–902.
De Broe, M.E., Paulus, G.J., Verpooten, G.A., Giuliano, R.A., Roels, F. and Tulkens, P.M. 1983. In “Proceedings of the 13th. International Congress of Chemotherapy: Side effects of antibiotics”. August 28-September 2, 1983, SE 8.4/1, part 86. Spitzy, K.H. and Karrer, K, eds., 86/11–86/23.
De Broe, M.E., Paulus, G.J., Verpooten, G.A., Roels, F., Buyssens, N., Wedeen, R.P. 1984. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int. 25: 643–652.
De Broe, M.E. 1985. Prevention of aminoglycoside nephrotoxicity. In: Proceedings of the European Dialysis and Transplantation Association- European Renal Association. Davison, A.M., and Guillow, P.J., eds., Bailliere Tindall Pub., London, Vol 22: 959–973.
Fabre, J., Rudhart, M., Blanchard, P. and Regamey, C. 1976. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int. 10: 444–449.
Giuliano, R.A., Paulus, G.J., Verpooten, G.A., Pattyn, V.M., Pollet, D.E., Nouwen, E.J., Laurent, G., Carlier, M.B., Maldague, P., Tulkens, P.M. and De Broe, M.E. 1904. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 26: 838–847.
Giuliano, R.A., Verpooten, G.A., Verbist, L., Wedeen, R.P. and De Broe M.E. 1986 a. In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J. Pharmacol. Exp. Ther. 236: 1470–475.
Giuliano, R.A., Verpooten, G.A. and De Broe, M.E. 1986 b. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides. Am. J. Kidney Dis. 8: 297–303.
Houghton, D.C., Hartnett, M.L., Campbell-Boswell, M., Porter, G. and Bennett, W. 1976. A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am. J. Pathol. 82: 589–612.
Josepovitz, C., Pastoriza-Munoz, E., Timmerman, D., Scott, M., Feldman, S. and Kaloyanides, G.J. 1982. Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations. J. Pharm. Exp. Ther. 233: 314–321.
Just, M. and Habermann, E. 1977. The renal handling of polybasic drugs. 2. In vitro studies with brush border and lysosomal preparations. Naunyn-Schmiedeberg’s Arch. Pharmacol. 300: 67–76.
Kaloyanides, G.J. and Pastoriza-Munoz, E. 1980. Aminoglycoside nephrotoxicity. Kidney Int. 18: 571–582.
Kleinknecht, D., Landais, P. and Goldfard, B. 1985 Drug-associated acute renal failure. A prospective multicenter report. In: Proceedings of the European Dialysis and Transplantation Association – European Renal Association. Davison, A.M. and Guillou, P.J. eds. Bailliere Tindall Pub. London 22: 1002–1007.
Kosek, J.C., Mazz, R.I. and Cousins, M.J. 1974. Nephrotoxicity of gentamicin. Lab. Invest. 30: 48–57.
Laurent, G., Carlier, M.B., Rollman, B., Van Hoof, F. and Tulkens, P.M. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31: 3861–387O.
Lietman, P.S. 1985. Aminoglycosides and spectinomycin: aminocyclitols. In: Principles and practice of infectious diseases. 2nd Edition. Part I: Basic principles in the diagnosis and management of infectious diseases. Mandel, G.L., Douglas Jr, R.G. and Bennett, J.E., eds. John Wiley and Sons, New York, Chichester: 192–206.
Moore, R.D., Smith, C.R., Lipsky, J.J., Mellitis E.D., and Lietman, P.S. 1981. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann. Intern. Med. 100: 352–357.
Pattyn, V.M., Verpooten, G.A., Giuliano, R.A., Zheng, F.L. and De Broe, M.D. 1987. Effect of hyperfiltration, proteinuria and diabetes mellitus on the uptake kinetics of gentamicin in the kidney cortex of rats. J. Pharmacol. Exp. Ther. 244: 694–698.
Powel, S.H., Thompson, W.L., Luthe, M.A., Stern, R.C., Grossniklaus, D.A., Bloxham, D.D., Groden, D.L., Jacobs, M.R., Discenna, A.O., Cash, H.A. and Klinger, J.D. 1983. Once daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. J. Infect. Dis. 147: 918–932.
Reiner, N.E., Bloxham, D.D., and Thompson, W.L. 1978. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs. J. Antimicrob. Chemother. 4 (Suppl.A): 85–101.
Reymann, M.T., Bradac, J.A. and Cobbs, C.G. 1979. Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram negative bacillary disease. Antimicrob. Agents Chemother. l6: 353–365.
Silverblatt, F. and Kuehn, C. 1979. Autoradiography of gentamicin uptake by the rat proximal tubular cell. Kidney Int. 15: 335–3-5.
Smith, C.R., Maxwell, R.R. and Edwards, C.Q. 1978. Nephrotoxicity induced by gentamicin and amikacin. John Hopkins Med. J. 142: 85–90.
Tulkens, P.M., De Broe, M.E., Maldague, P. and Heuson-Stiennon, J.A. 1984. Lysosomal alterations in aminoglycoside-induced acute renal failure. In: Acute Renal Failure: correlations between morphology and function. Solez, K., and Whelton, A., eds. Marcel Dekker, Pub., New York: 299–327.
Verpooten, G.A., Giuliano, R.A., Pattyn, V.M., Schärpé, S.L. and De Broe, M.E. 1986. Renal cortical uptake kinetics of gentamicin in rats with impaired renal fimction. Am. J. Kidney Dis. 8: 304–307.
Verpooten, G.A., Giuliano, R.A., Verbist, L., Eestermans, G. and De Broe, M.E. 1988. A once-daily dosage schedule decreases the acciomulation of gentamicin and netilmicin in the renal cortex of humans. Submitted.
Wedeen, R.P., Batuman, V., Cheeks, E.M., Marquet, E. and Sobel, H. 1983.Transport of gentamicin in rat proximal tubule. Lab. Invest. 48:212–223.
Whelton, A. 1985 Therapeutic initiative for avoidance of aminoglycoside toxicity. J. Clin. Pharmacol. 25: 67–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
De Broe, M.E., Giuliano, R.A., Verpooten, G.A. (1989). Aminoglycoside Nephrotoxicity: Mechanism and Prevention. In: Amerio, A., Coratelli, P., Campese, V.M., Massry, S.G. (eds) Drugs, Systemic Diseases, and the Kidney. Advances in Experimental Medicine and Biology, vol 252. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8953-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8953-8_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8955-2
Online ISBN: 978-1-4684-8953-8
eBook Packages: Springer Book Archive